New trends in the development of AMPA receptor antagonists

about

New AMPA antagonists in epilepsy.

P2860

Q38025721-E6ACA576-18C5-4712-BA96-E6F33E4D0480

P2860

New trends in the development of AMPA receptor antagonists

Item

http://www.wikidata.org/entity/Q59070865

description

article

@en

im August 2004 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2004

@uk

name

New trends in the development of AMPA receptor antagonists

@en

New trends in the development of AMPA receptor antagonists

@nl

type

Item

label

New trends in the development of AMPA receptor antagonists

@en

New trends in the development of AMPA receptor antagonists

@nl

prefLabel

New trends in the development of AMPA receptor antagonists

@en

New trends in the development of AMPA receptor antagonists

@nl

P1476

New trends in the development of AMPA receptor antagonists

@en

P2093

Alba Chimirri

http://www.w3.org/2001/XMLSchema#string

P2860

ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core

In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels

Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.

Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173.

Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.

Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse.

AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.

The tetrameric structure of a glutamate receptor channel.

P304

1199-1213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.14.8.1199

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Letizia Barreca

Laura De Luca

Rosaria Gitto

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

drug discovery

New trends in the development of AMPA receptor antagonists

about

P2860

P2860

New trends in the development of AMPA receptor antagonists

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P921